Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $63.2 million.

  • Cryo Cell International's Liabilities and Shareholders Equity rose 37.29% to $63.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $256.7 million, marking a year-over-year increase of 189.62%. This contributed to the annual value of $64.7 million for FY2024, which is 0.0% changed from last year.
  • Cryo Cell International's Liabilities and Shareholders Equity amounted to $63.2 million in Q3 2025, which was up 37.29% from $64.4 million recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Liabilities and Shareholders Equity registered a high of $105.3 million during Q1 2021, and its lowest value of $50.2 million during Q2 2021.
  • In the last 5 years, Cryo Cell International's Liabilities and Shareholders Equity had a median value of $64.4 million in 2025 and averaged $64.8 million.
  • Per our database at Business Quant, Cryo Cell International's Liabilities and Shareholders Equity soared by 13533.07% in 2021 and then plummeted by 4793.28% in 2022.
  • Cryo Cell International's Liabilities and Shareholders Equity (Quarter) stood at $60.7 million in 2021, then increased by 6.97% to $64.9 million in 2022, then fell by 0.32% to $64.7 million in 2023, then changed by 0.0% to $64.7 million in 2024, then fell by 2.33% to $63.2 million in 2025.
  • Its last three reported values are $63.2 million in Q3 2025, $64.4 million for Q2 2025, and $64.4 million during Q1 2025.